FDA Approves LEQEMBI IQLIK: First At-Home Injection for Alzheimer’s Maintenance Therapy
For individuals living with early Alzheimer’s disease (AD) and their care partners, managing a chronic condition often involves frequent clinic visits and complex treatment schedules. A major advancement in easing […]
FDA Approves LEQEMBI IQLIK: First At-Home Injection for Alzheimer’s Maintenance Therapy Read More »
